ECURE previously announced that the first patient dosed with ECUR-506 for OTC deficiency achieved a complete clinical ...

Clinical research organisation (CRO) Icon has begun the integration of Medidata Clinical Data Studio into its clinical ...

IGC Pharma has added HHS in Canada as a new clinical site for its Phase II CALMA trial of IGC-AD1 to treat agitation in ...

Onctura has dosed the first subject in the Phase II OCULE-01 trial of oral roginolisib in individuals with metastatic uveal ...

The US is set to withdraw from the WHO following Trump's disagreements regarding the agency's handling of the Covid-19 ...

Biotech and biopharma companies have battled with a drought of private investment in recent years but could now face government funding cuts.

The two simultaneous Incyte trials in HS saw more than 40% of patients on povorcitinib achieving a clinical response.